Overview

Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide

Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to see whether pomalidomide can help people with myeloma. Researchers also want to find out if pomalidomide is safe and tolerable.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborator:
Celgene
Treatments:
BB 1101
Cyclophosphamide
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Pomalidomide
Thalidomide